Anteris Technologies Global (AVR) Net Income towards Common Stockholders (2024 - 2026)
Anteris Technologies Global (AVR) reported Net Income towards Common Stockholders of -$22.9 million for Q1 2026, down 4.41% year-over-year from -$24.0 million in Q1 2025, and down 5.79% quarter-over-quarter from -$21.6 million in Q4 2025.
Anteris Technologies Global (AVR) Net Income towards Common Stockholders (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has 3 years of Net Income towards Common Stockholders data on file, last reported at -$22.9 million in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$22.9 million, down 4.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$87.8 million (down 33.37% YoY), and the FY2025 annual result was -$86.8 million, down 44.59% from the prior year.
- Net Income towards Common Stockholders slipped to -$22.9 million in Q1 2026 per AVR's latest filing, from -$21.6 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$3.3 million in Q4 2024 and troughed at -$22.9 million in Q1 2026.
- A 3-year average of -$18.9 million and a median of -$21.6 million in 2025 frame the typical range for Net Income towards Common Stockholders.
- On a YoY basis, Net Income towards Common Stockholders climbed as much as 1.9% in 2025 and fell as far as 556.51% in 2025.
- A 3-year view of Net Income towards Common Stockholders shows it stood at -$3.3 million in 2024, then plunged by 556.51% to -$21.6 million in 2025, then slipped by 5.79% to -$22.9 million in 2026.
- Business Quant data shows AVR's Net Income towards Common Stockholders at -$22.9 million in Q1 2026, -$21.6 million in Q4 2025, and -$22.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.00 Mn |
| 10 | Anteris Technologies Global | 779.46 Mn | 779.43 Mn | 380,000.00 | -22.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.90 Mn |
| Dec 31, 2025 | -21.65 Mn |
| Sep 30, 2025 | -22.21 Mn |
| Jun 30, 2025 | -21.06 Mn |
| Mar 31, 2025 | -21.93 Mn |
| Dec 31, 2024 | -3.30 Mn |
| Sep 30, 2024 | -21.79 Mn |
| Jun 30, 2024 | -18.82 Mn |
| Mar 31, 2024 | -16.15 Mn |